SLC3A2 and familial pancreatic carcinoma: We performed in vitro experiments to validate that SLC3A2 knockdown could improve the sensitivity to ferroptosis in a colorectal cancer cell-line and a pancreatic cancer cell-line (Figures 3F,G).